We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Haiti Cholera Outbreak Largest in Recent Memory

By HospiMedica International staff writers
Posted on 30 Jan 2013
The cholera outbreak in Haiti accounted for 57% of all cholera cases and 45% of cholera deaths reported to the World Health Organization (WHO; Geneva, Switzerland) in 2010 and 2011, according to a new study.

Researchers at the US Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA) reported the findings of the Haitian National Cholera Surveillance System (NCSS) set up in October 2010—nearly 10 months after the devastating earthquake that shattered the country—when Haiti was stricken by epidemic cholera, which has so far sickened more than 600,000 people and killed nearly 7,500. The cholera was possibly inadvertently introduced by troops from Southeast Asia who formed part of the earthquake relief effort, as the strain involved is similar to the one circulating in Asia, and different from those found in Latin America and the USA.

Within 29 days of the first report, cases of Vibrio cholerae (serotype Ogawa, biotype El Tor) were confirmed in all 10 administrative departments in Haiti. Through October 20, 2012, the Haiti Public Health Ministry reported 604,634 cases of infection, 329,697 hospitalizations, and 7,436 deaths from cholera. The ministry isolated V. cholerae O1 from 1,675 of 2,703 stool specimens tested (62%). The cumulative attack rate was 5.1% at the end of the first year, and 6.1% at the end of the second year.

The researchers reported that the cumulative case fatality rate consistently trended downward, reaching 1.2% at the close of year two, with departmental cumulative rates ranging from 0.6% to 4.6%. Within three months after the start of the epidemic, the rolling 14-day case fatality rate was 1% and remained at or below this level with few, brief exceptions. Overall, the cholera epidemic in Haiti accounted for 57% of all cholera cases and 53% of all cholera deaths reported to the WHO in 2010, and 58% of all cholera cases and 37% of all cholera deaths in 2011.

“The earthquake had seriously damaged the country's health care, water and sanitation systems, which had already been precarious; only 63% of Haiti's 9.8 million people had access to an improved drinking water source, just 12% got piped and treated water, and only 17% had adequate sanitation,” concluded lead author Ezra Barzilay, MD, and colleagues of the CDC. “The international goal in a cholera outbreak is a case fatality rate of no more than 1%. That was made more challenging because of these conditions.”

Related Links:
World Health Organization
US Centers for Disease Control and Prevention


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
12-Channel ECG
CM1200B
New
Absorbable Monofilament Mesh
Phasix Mesh
New
Electrically Operated Patient Lifter
SVL 205

Channels

Surgical Techniques

view channel
Image: For the first time, a fluorescent-guided nerve imaging agent has shown promise for use in humans (Photo courtesy of VUMC)

Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery

Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more